Published in Br J Hosp Med on December 20, 1994
HCV infection in blood donors. Br J Hosp Med (1995) 0.75
HCV infection in blood donors. Br J Hosp Med (1995) 0.75
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut (2004) 1.93
Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol (1993) 1.83
Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. J Infect Dis (1998) 1.77
Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat (2009) 1.63
HCV and PCR negativity. Lancet (1992) 1.43
Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA. J Virol Methods (2001) 1.43
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study. J Hepatol (2001) 1.42
Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol (2001) 1.40
The reliability of serological tests for the diagnosis of genital herpes: a critique. Pathology (1993) 1.20
Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol (1993) 1.17
Hepatitis C in blood donors. Lancet (1993) 1.10
TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. J Gen Virol (1999) 1.02
Intradermal hepatitis B vaccine. Lancet (1987) 0.99
Antibody to both human herpesvirus 6 and cytomegalovirus. Lancet (1988) 0.97
Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. Virology (2000) 0.95
Intradermal vaccination against hepatitis B. Lancet (1986) 0.95
Abnormal responses of rheumatoid arthritis lymphocytes to Epstein-Barr virus infection in vitro: evidence for multiple defects. Ann Rheum Dis (1985) 0.93
HIV-1 in semen: determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations. J Med Virol (1999) 0.92
The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy. J Viral Hepat (2013) 0.92
In situ hybridization studies of adenoviral infections of the lung and their relationship to follicular bronchiectasis. Am Rev Respir Dis (1989) 0.92
Evidence for B cell activation in patients with active rheumatoid arthritis. Clin Exp Immunol (1984) 0.91
Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex. Clin Exp Immunol (2007) 0.90
Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals. Who is at risk? BMJ (1997) 0.90
The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgM. Trent HCV Study Group. J Hepatol (1996) 0.88
Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group. J Hepatol (1996) 0.88
Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations. J Viral Hepat (2008) 0.87
Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management. J Viral Hepat (2007) 0.86
Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1. J Gen Virol (1999) 0.86
Hepatitis G infection: role in cryptogenic chronic liver disease and primary liver cell cancer in the UK. Trent Hepatitis C virus Study Group. J Viral Hepat (1998) 0.83
Studies to show that with podophyllotoxin the early replicative stages of herpes simplex virus type 1 depend upon functional cytoplasmic microtubules. J Med Microbiol (1996) 0.83
Defective rheumatoid lymphocyte function assessed by Epstein-Barr virus infection in vitro. Lancet (1982) 0.82
Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA). J Med Virol (1998) 0.82
Playing in a scrapyard and acute renal failure. Lancet (1997) 0.81
Prevalence and risk factors for hepatitis C virus infection in Kech District, Balochistan, Pakistan: most infections remain unexplained. A cross-sectional study. Epidemiol Infect (2011) 0.80
Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons. Clin Exp Immunol (1995) 0.80
Ebola virus transmission. Int J Exp Pathol (1995) 0.79
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease. J Viral Hepat (2008) 0.78
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes Immun (2013) 0.78
GBV-C/HGV coinfection in HIV-1-positive men: frequent detection of viral RNA in blood plasma but absence from seminal fluid plasma. J Med Virol (1998) 0.76
Chronic hepatitis in children after liver transplantation: role of hepatitis C virus and hepatitis G virus infections. J Hepatol (1998) 0.76
Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries. J Viral Hepat (2014) 0.76
Vertical transmission of hepatitis C. Lancet (1995) 0.76
Concurrent infection with hepatitis B and C viruses. BMJ (1994) 0.75
Varicella vaccine in pregnancy. Varicella zoster immunoglobulin should be given after exposure to the virus. BMJ (1997) 0.75
Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8. Br J Haematol (1998) 0.75
A cell surface monoclonal antibody (H366) helps to discriminate human cytotoxic from suppressor T cells. Clin Exp Immunol (1985) 0.75
Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. Sex Transm Infect (1999) 0.75
Human herpesvirus-6. J Med Microbiol (1992) 0.75
The nuclear arms race and the Third World. JAMA (1985) 0.75
Is there a role for Epstein-Barr virus in the aetiology of rheumatoid arthritis? Br J Rheumatol (1988) 0.75
Receptors for mouse erythrocytes on human lymphocytes: technical aspects. J Immunol Methods (1984) 0.75
Cytomegalovirus meningoencephalitis in healthy adults with coincident infection by human herpesvirus type 6. Aust N Z J Med (1992) 0.75
Intrauterine growth retardation: report of case and review of literature. J Am Osteopath Assoc (1979) 0.75
Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol (1994) 0.75
Congenital amniotic band syndrome: report of a familial recurrence. J Am Osteopath Assoc (1988) 0.75
The effects of cyclosporin A on the early responses of B and T cells to Epstein-Barr virus infection. Immunol Lett (1986) 0.75
Modulation of Epstein-Barr virus-induced B-cell activation by concanavalin A. Cell Immunol (1985) 0.75
Variation in expression of mouse erythrocyte receptors on Epstein-Barr virus-induced B-cell lines. Immunol Lett (1984) 0.75